Please use this identifier to cite or link to this item: http://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1261
Title: Nanoparticles of two ZnO Precursors as an Encapsulating Matrix of Mangiferin: Associated Studies to Cytotoxic Effects on Liver Cancer Cells Hep-G2 and Healthy Lung Cell Beas-2B
Authors: Razura Carmona, Francisco Fabián
Herrera Martínez, Mayra
Sáyago Ayerdi, Sonia G.
Pérez Larios, Alejandro
Montalvo González, Efigenia
Ramírez Mares, Marco Vinicio
Sánchez Burgos, Jorge Alberto
Keywords: ZnO precursors
mangiferin
anticiclooxigenase
antitopoisomerase and toxicity
Issue Date: Jan-2022
Publisher: Springer Nature
Citation: Razura-Carmona, F.F., Herrera-Martínez, M., Sáyago-Ayerdi, S.G. et al. Nanoparticles of two ZnO Precursors as an Encapsulating Matrix of Mangiferin: Associated Studies to Cytotoxic Effects on Liver Cancer Cells Hep-G2 and Healthy Lung Cell Beas-2B. J Clust Sci 33, 163–171 (2022). https://doi.org/10.1007/s10876-020-01957-7
Series/Report no.: Journal of Cluster Science;Volume 33, issue 1 January 2022
Abstract: Abstract In recent years, metal oxides have been studied as an encapsulating matrix nevertheless, few studies the effect that can exist between different precursors to form this type of nanomaterials; In this paper, we compare its ability as a mangiferin (MG) nanoencapsulated. Phytochemical that has been studied for its generous biological properties like anti-inflammatory, antiproliferative, and others; the nanoparticles (NP’s) be synthesized with zinc nitrate and zinc acetate. The results showed modifications in the morphology of the ZnO associated with the precursor but, there is no significant difference between any treatment that is associated with antitopoisomerase activity however, ZnOA-MG is statistically the best treatment by reducing in greater proportion the production of COX-II prostaglandins (97.38 ± 7.09%) with a significant difference (p < 0.05) compared toCOX-I (68.02 ± 2.14%) but, it is not considered a selective treatment moreover ZnOA-MG proved to be the least hepatotoxic (IC50, 140.19 ± 13.10 µg/mL) while ZnON is the most cytotoxic for HEP-G2 and BEAS-2B (IC50, 51.27 ± 4.72 and 26.91 ± 3.21 µg/mL). All treatments change the morphology of erythrocytes to low concentrations (25 µg/mL). Therefore the MG load benefits the biological impact of ZnO.
Description: Artículo
URI: http://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1261
ISSN: 1572-8862 online
1040-7278 print
Appears in Collections:2414 Artículos

Files in This Item:
File Description SizeFormat 
Nanoparticles of two ZnO Precursors as an Encapsulating Matrix.pdfDocumento1 MBAdobe PDFView/Open
Enlace a_Nanoparticles of two ZnO Precursors as an Encapsulating Matrix.htmEnlace a publicación48.42 kBHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.